pH-dependent cadmium binding to hemoglobin: Implications for human excretion.

Area of Science:

• Toxicology
• Biochemistry
• Environmental Health

Background:

• Cadmium (Cd) has a long half-life in human organs (30 years) but a shorter one in blood (3-4 months).
• Reducing the body's cadmium burden is critical, with blood Cd elimination being a key step.
• Currently, effective methods to promote cadmium elimination from blood are lacking.

Purpose of the Study:

• To investigate the distribution and binding of cadmium in blood.
• To explore the role of pH in cadmium-hemoglobin interactions.
• To identify potential strategies for enhancing cadmium excretion from blood.

Main Methods:

• Analysis of cadmium distribution in blood cells and serum from occupationally exposed workers.
• Identification of cadmium-binding proteins using biochemical techniques.
• Investigation of pH effects on cadmium binding to hemoglobin (Hb) in vitro.
• Cellular experiments to assess cadmium release from blood cells under varying pH conditions.

Main Results:

• Over 98% of blood cadmium was found concentrated in blood cells, primarily bound to hemoglobin (Hb).
• Decreased pH significantly reduced cadmium's binding capacity and available binding sites on Hb.
• Lowering blood pH promoted the release of cadmium from blood cells into the serum.

Conclusions:

• Hemoglobin is the main cadmium-binding protein in blood cells.
• Blood pH is a critical factor influencing cadmium-hemoglobin binding.
• Manipulating blood pH presents a potential therapeutic strategy to enhance cadmium excretion and reduce body burden.